Brand Name : Adlyxin
Marketing Authorization Holder : SANOFI
℞ Prescription Required
Temp Controlled Express Courier
Adlyxin brand medicine goes by the trade name Lyxumia in Europe.
Prescription Adlyxin injections (or Lyxumia in the UK) are used by adults with type 2 diabetes along with exercise and diet to lower blood sugar. Adlyxin is not insulin and not for the treatment of type 1 diabetes.
Adlyxin pens are disposable and pre-filled. Adlyxin dose begins at 10mcg once daily injected under the skin and may be increased to 20mcg after 15 days.
Adlyxin is injected 1 hour before your first daily meal at the same time daily. Take Adlyxin exactly as prescribed and read the brochure to follow instructions accurately. Your doctor may change your dose, but do not change the Adlyxin dose on your own. Allow your healthcare provider to teach you how to use Adlyxin pens. If a dose is missed, then use Adlyxin within one hour of the next meal.
Each Adlyxin pen must be activated before its first use. Do not share your pen with others .
Injections of Adlyxin are under the skin of your thigh, abdomen or upper arm, never in a vein or muscle. Rotate or use different injection sites for each dose.
It is important to monitor your blood sugar levels and share this with your physician. Your doctor may adjust your Adlyxin dose according to your blood sugar levels. Changes in dose may also occur when there is stress, illness, changes in diet habits or exercise levels or when you have significant weight loss or if you are changing other medicines that you take.
In 2019, when comparing Adlyxin pen price to USA Adlyxin coupon price, InsulinHub was found to offer a discount of approximately 40% in Adlyxin savings.
Buy Adlyxin pens from InsulinHub.com for the best Adlyxin pen price.
Adlyxin is a medication primarily used to treat type 2 diabetes. This medicine adjunct to diet and exercise to improve glycemic control.
Adlyxin is prescribed to help control blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists, which work by stimulating insulin release in response to meals and by reducing the amount of glucose produced by the liver.
The product may appear different from
the product illustrated here